Who invested in Actuate Therapeutics?
Actuate Therapeutics's investors include Tech Coast Angels, Kairos Ventures, DEFTA Partners and Bios Partners.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$122Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $22M sold, first sale Apr 2019
From Actuate Therapeutics's own website: 9 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Actuate Therapeutics's investors include Tech Coast Angels, Kairos Ventures, DEFTA Partners and Bios Partners.
Actuate Therapeutics has raised $122M across 2 rounds since 2019.
Actuate Therapeutics's most recent round was an Undisclosed round of $100M in Nov 2025.
Its most recent round, $100M in Nov 2025, is also its largest on record.
Actuate Therapeutics's first round on record, in May 2019, was backed by Kairos Ventures, Tech Coast Angels and DEFTA Partners and 1 others.
Actuate Therapeutics's latest named round is an Undisclosed round, in Nov 2025.
Actuate Therapeutics is based in the United States.
Kairos Ventures led the Series B in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.